Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAristotle University Of Thessaloniki

About this trial

The COMFORT study will evaluate an artificial intelligence-based platform developed to support the clinical assessment of kidney and prostate cancer. The platform utilises imaging data to provide AI-generated outputs intended to assist clinicians in the assessment of suspected lesions.

The primary objective of the study is to assess the role of the COMFORT platform in the clinical decision making process of clinicians managing kidney or prostate cancer cases.

Secondary objectives include evaluation of the performance of AI models on anatomical segmentations, tumor characterisation (localisation, volumetric measurements, lesion classification, and scoring (e.g., Bosniak, PI-RADS, RENAL). Also the acceptability, usability, utility and trustworthiness of the AI models will be evaluated.

In addition, potential causes of privacy leakage associated with the COMFORT AI models will be evaluated as part of the platform's privacy assessment.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Healthcare professional resident or specialised in Urology

Healthcare professional resident or specialised in Radiology

Proficient in English

Disqualifiers

None

Trial population

Healthcare professionals participating in the study who use the COMFORT platform during the study period. Participants will use the platform as specified in the study protocol and data related to platform assessment and study outcomes will be collected

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Medical Reading

    Other intervention

    Participants will perform medical reading of abdominal CT for renal cancer and prostate mpMRI for prostate cancer, without access to AI output using the COMFORT platform.

  • AI assisted Medical reading

    Other intervention

    Participants will perform medical reading of abdominal CT for renal cancer and prostate mpMRI for prostate cancer, with access to AI output using the COMFORT platform.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Urologists2 interventions
Group B: Radiologists2 interventions

Trial outcomes

Primary outcomes

1

Accuracy of the multimodal AI algorithms

Accuracy of the multimodal AI algorithms will be assessed by comparing model predictions with the clinician-reported reference standard for each suspected lesion. Accuracy will be calculated for each applicable cancer type, with bootstrap confidence intervals.

Time frame
Through study completion, an average of 6 months.
2

Precision of the multimodal AI algorithms

Precision of the multimodal AI algorithms will be assessed by comparing model predictions with the clinician-reported reference standard for each suspected lesion. Precision will be calculated for each applicable cancer type, with bootstrap confidence intervals.

Time frame
Through study completion, an average of 6 months.
3

F1-score of the multimodal AI algorithms

F1-score will be calculated to assess the classification performance of the multimodal AI algorithms against the clinician-reported reference standard for each suspected lesion. F1-score will be calculated for each applicable cancer type, with bootstrap confidence intervals.

Time frame
Through study completion, an average of 6 months.
4

Sensitivity of the multimodal AI algorithms

Sensitivity (recall) will be calculated to assess the ability of the multimodal AI algorithms to correctly identify positive cases relative to the clinician-reported reference standard. Sensitivity will be calculated for each applicable cancer type, with bootstrap confidence intervals.

Time frame
Through study completion, an average of 6 months.

Secondary outcomes

1

Acceptability of the COMFORT platform

Clinician acceptability of the COMFORT platform will be assessed using the Technology Acceptance Model (TAM), applicable study questionnaires, and structured interviews. Questionnaire scores will be summarized using the median and interquartile range (IQR) for each study site and across the study. Comparisons between study sites will be performed using non-parametric hypothesis testing.

Time frame
Through study completion, an average of 6 months.
2

Usability of the COMFORT platform

Clinician-reported usability of the COMFORT platform will be assessed using the System Usability Scale (SUS). The SUS provides a total score ranging from 0 to 100, with higher scores indicating greater perceived usability. Scores will be summarized using the median and interquartile range (IQR) for each study site and across the study. Comparisons between study sites will be performed using non-parametric hypothesis testing.

Time frame
Through study completion, an average of 6 months.
3

Perceived trustworthiness of COMFORT AI outputs

Clinicians' perceived trustworthiness of AI-generated outputs will be assessed using the Trustworthiness of AI Output questionnaire and structured interviews. Questionnaire scores will be summarized using the median and interquartile range (IQR) for each study site and across the study.

Time frame
Through study completion, an average of 6 months.
4

Perceived information integration

Clinicians' perceptions of the integration of information provided by the COMFORT platform will be assessed using the Perceived Information Integration questionnaire and structured interviews. Questionnaire scores will be summarized using the median and interquartile range (IQR) for each study site and across the study.

Time frame
Through study completion, an average of 6 months.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Aristotle University Of Thessaloniki

Lead sponsor

Charite University, Berlin, Germany

Collaborator

Technical University of Munich

Collaborator

University of Patras

Collaborator

Radboud University Medical Center

Collaborator

Fraunhofer Institute for Digital Medicine MEVIS

Collaborator

University of Salerno

Collaborator

Hospital Universitario 12 de Octubre

Collaborator

Federico II University

Collaborator

This trial is not recruiting at the moment. You can still explore other options: